on SARTORIUS STED BIO (EPA:DIM)
Sartorius Stedim Biotech Issues Capital Structure Update
Sartorius Stedim Biotech SA has released a statement regarding its shares and voting rights. As of December 31, 2025, the company's issued capital totaled 97,330,405 shares. The firm reported a total of 164,793,739 theoretical voting rights, inclusive of treasury shares. The net voting rights, excluding these shares, amounted to 164,759,753. This announcement aligns with Article L 233-8-II of the French Code of Commerce and AMF's Article 223-6. The company is headquartered in Aubagne, France, and listed under the Euronext ticker DIM.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all SARTORIUS STED BIO news